Thomas Flaten
Stock Analyst at Lake Street
(0.91)
# 3,738
Out of 4,876 analysts
25
Total ratings
34.38%
Success rate
-11.08%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDSX Biodesix | Maintains: Buy | $3 → $2 | $0.27 | +640.74% | 1 | May 14, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $40 → $35 | $19.93 | +75.62% | 6 | May 6, 2025 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $8 | $3.21 | +149.22% | 2 | Mar 7, 2025 | |
| EVAX Evaxion | Maintains: Buy | $35 → $6 | $2.65 | +126.42% | 2 | Feb 4, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $9 | $6.27 | +43.54% | 2 | Jan 8, 2025 | |
| DERM Journey Medical | Initiates: Buy | $9 | $6.99 | +28.76% | 1 | Sep 6, 2024 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $0.65 | +361.54% | 3 | Mar 12, 2024 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $19 → $11 | $2.34 | +370.09% | 3 | Mar 5, 2024 | |
| BLFS BioLife Solutions | Maintains: Buy | $34 → $25 | $21.60 | +15.77% | 2 | Aug 9, 2023 | |
| ENSC Ensysce Biosciences | Maintains: Buy | $14,400 → $1,440 | $2.25 | +63,900.00% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $3.78 | +111.64% | 1 | Jul 7, 2022 |
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $3 → $2
Current: $0.27
Upside: +640.74%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $19.93
Upside: +75.62%
Aquestive Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $3.21
Upside: +149.22%
Evaxion
Feb 4, 2025
Maintains: Buy
Price Target: $35 → $6
Current: $2.65
Upside: +126.42%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $6.27
Upside: +43.54%
Journey Medical
Sep 6, 2024
Initiates: Buy
Price Target: $9
Current: $6.99
Upside: +28.76%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.65
Upside: +361.54%
Achieve Life Sciences
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $2.34
Upside: +370.09%
BioLife Solutions
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $21.60
Upside: +15.77%
Ensysce Biosciences
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $2.25
Upside: +63,900.00%
Jul 7, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $3.78
Upside: +111.64%